Our Ref: SEC/PSX/23/25 October 24, 2025
7he Genera/ Manager
Pakistan Stock Exchange Limited Stock Exchange Building
Stock Exchange Road Karachi
Dear Sir,
Form-7
Subject: Financial Results for the Third Quarter and Nine Months Ended September 30,
2025
We have to inform you that the Board of Directors of our Company in their meeting held on Friday, October 24, 2025 at 03:00 p.m. at Karachi have recommended the following:
CASH DIVIDEND
NIL
BONUS SHARES
NIL
RIGHT SHARES
NIL
The financial results of the Company for the third quarter and nine months ended September 30, 2025, are attached as Annexure — A, along with the following statements:
Statement of Financial Position
Statement of Changes in Equity
Statement of Cash Flows
The Quarterly Report of the Company for the third quarter and nine months ended September 30, 2025, will be transmitted through PUCARS separately, within the specified time.
Yours truly,
Ma
qba
Company Sec tary
Encl. as above
Copy to:
The Executive Director/HOD Offsite-II Department
Securities & Exchange Commission of Pakistan
Corporate Supervision Department-Company Law Division 63, NIC Building, Jinnah Avenue, Islamabad
Page 1 of 1 Pakistan Oxygen Limited
P.0.Box 484a Dockyard Road, West Wharf. Karachi - 74000
Phone: +9E°E° 1 3L°31 3361-9 Fax *9221 3231 1509 Email info.pkñpakoxy en.com Web www.pakoxy,en.cont
Annexure “A”
Pakistan Oxygen Limited
Condensed Interim Statement of Profit or Loss (Unaudited) For The Nine Months Ended September 30, 2025
For the nine months ended For the three months ended September 30, September 30, September 30, September 30,
2025 2024 2025 2024
(Restated) (Restated)
Note -----—-Rupees in '000--—------ --------Rupees in ’000----------
Gross sales | 5 | 10,915,315 9,516,778 | 3,924,535 3,211,516 | |
Sales tax | (1,440,448) (1,244,479) | (520,723) (432,733) | ||
Net sales | 9,474,867 8,272,299 | 3,403,812 2,778,783 | ||
Cost of sales | 5 | (5,760,159) (6,072,653) | (1,979,825) (2,026,808) | |
Gross profit | 3,714,708 2,199,646 | 1,423,987 751,975 |
(285,971) (314,004) (217,211) | (415,833) (251,085] (95,213) |
(123,462 (114,155 (87,010 | (160,349 (87,070 (26,471 |
Distribution and marketing expenses Administrative expenses
Other operating expenses
(817,186) (762,131) | (324,627) (273,890) | |||
Operating profit before other income | 2,897,522 | 1,437,515 | 1,099,360 | 478,085 |
Gain on sale of non current assets classified as held for sale | 50,424 | |||
Other income | 33,199 85,165 | 13,370 959 | ||
Operating pro'Fit | 2,930,721 | 1,573,104 | 1,112,730 | 479,044 |
Finance cost | (394,761) | (809,964) | (100,161) | 249 614 |
Profit before levy and taxation | 2,535,960 | 763,140 | 1,012,569 | 229,430 |
Minimum tax differential - levy | (55,854) | (14, 028) | (22,506) | 12 91 ) |
Profit before taxation | 2,480,106 | 749,112 | 990,063 | 216,513 |
Taxation | (971,421) | (291,913) | (382,942) | 70 224) |
Profit for the period
Earnings per share - basic and diluted (Rupees)
1,508,685 457,199
17.32 5.25
607,121 146,289
6.97 1 68
The annexed notes 1 to 20 fom an integral part of these condensed interim financial statements.
Secreta
Page 1 of 4
Pakistan Oxygen Limited
Condensed Interim Statement of Financial Position As at September 30, 2025
NoteSeptember 30, December 31,
2025 2024
(Unaudited) (Audited)
------- Rupees in 'OOO ------
Assets Non-current assets | ||||
Property, plant and equipment | 6 | 13,296,643 | 13,416,451 | |
Intangible assets | 25,46?’ | 14,380 | ||
Investment in subsidiary | 10 | 10 | ||
Long term loans | 21,665 | 3,956 | ||
Long term deposits | 80,610 | 80,610 | ||
Current assets | 13,424,395 | 13,515,407 | ||
Stores and spares | 621,636 | 547,889 | ||
Stock-in-trade | 7 | 745,758 | 797,098 | |
Trade debts | 2,312,535 | 1,795,432 | ||
Loans and advances | 119,556 | 29,71 1 | ||
Deposits and prepayments | 551,839 | 445,548 | ||
Other receivables | 8 | 908,200 | 1,146,870 | |
Taxation - net receivable | 187,757 | |||
Cash and bank balances | 1,178,180 | 562,660 | ||
6,437,704 | 5,512,965 | |||
Non current assets classified as held for sale | 5?’,449 | 57,449 | ||
Total assets | 19,919,548 | 19,085,821 | ||
Equity and Liabilities | ||||
Share capital and reserves | ||||
Authorised share capital | ||||
150,000,000 (2024: 150,000,000 ) Ordinary shares of Rs. 10 each | 1,500,000 | 1,500,000 | ||
Issued, subscribed and paid-up capital | ||||
87,124,228 (2024: 87,124,228) Ordinary shares of Rs. 10 each | 871,243 | 871,243 | ||
Capital reserves | ||||
Share Premium | 595,092 | 595,092 | ||
Surplus on revaluation of property, plant and equipment Revenue reserves | 4,186,648 | 4,186,648 | ||
General reserves | 3,693,204 | 2,985,666 | ||
Unappropriated profit | 1,508,685 | 707,538 | ||
9,983,629 | 8,474,944 | |||
Non-current liabilities | 10,854,872 | 9,346,187 | ||
Long term deposits | 286,638 | 260,063 | ||
Long term financing | 9 | 2,832,817 | 3,539,714 | |
Lease liabilities | 10 | 7,983 | 13,379 | |
Deferred capital grant | 1 1 | 270,774 | 345,768 | |
Deferred liabilities | 594,2?’4 | 263,928 | ||
Current liabilities | 3,992,486 | 4,422,852 | ||
Trade and other payables | 2,909,306 | 2,737,951 | ||
Short term borrowings | 1,388,387 | 1,987,007 | ||
Un-claimed dividend | 17,845 | 18,045 | ||
Taxation - net payable | 128,615 | |||
Current maturity of long term financing | 9 | 521,792 | 460,608 | |
Current portion of lease liabilities | 10 | 4,895 | 2,623 | |
Current portion of deferred capital grant | 1 1 | 101,350 | 1 10,548 | |
5,072,190 | 5,316,782 | |||
Total equity and liabilities | 19,919,548 | 19,085,821 | ||
Contingencies and Commitments | 12 | |||
Comp y Secreta
The annexed notes 1 to 20 form an integral part of these condensed interim financial statements.
Page 2 of 4
Pakistan Oxygen L¥n¥ed
Condensed lmer¥n Stammers of Changesh Equity (Unaud8ed) For Tñe N¥+c Months Endad September 30, 2026
Baknce as at Jcr«ary 1, Z024 (Audked)
Total compretunsive ir
Otler comprehensive income
Transfer to gereral reserves
Balance as at September 30, 2034 (Un-eud8ed}
Totsl compreturisive ircome for me period: Profit for me period
Otter comprehensive ir<>
- - 140,736
14fi,736 Z,065,G66 6,C3t,640
a57,199 457,199 467,1SS
(140,736) - •
70t,538 3,6fi3,204 9,3d6,167
Transfer to gareral reserves | - | - | 707,536 | (707,538) | - • | |||
Balance ac at September 30, 202a tUn•auatcaj | 4,166,646 | 4,t81,740 | 3,C93,204 | 1 506.665 | 5,Z01 66S " 10,46d,g72 |
The annexed notes I to 20 Arm cv ntepal psA of +cce condensed mt*ñm 8nsciel etate«ena.
en Limited
Page 3 of 4
Pakistan Oxygen Limited
Condensed Interim Statement of Cash Flows (Unaudited) For The Nine Months Ended September 30, 2025
September 30, September 30,
2025 2024
Note --------Rupees in ’000---------
Cash flow from operating activities | |||||
Cash generated from operations | 13 | 3,307,264 | 1,981,281 | ||
Finance cost paid | (472,082) | (751,272) | |||
Levy and income tax paid | (377,398) | (44,654) | |||
Post-retirement medical benefits paid | (4,012) | (258) | |||
Long-term deposits and loans receivable | (17,709) | (5,931) | |||
Long-term deposits payable | 26,575 | 2,889 | |||
Net cash generated from operating activities | 2,462,638 | 1,182,055 | |||
Cash flow from investing activities | |||||
Additions to property, plant and equipment | (526,326) | (574,248) | |||
Additions to intangibles assets | (16,193) | ||||
Proceeds from disposal of property, plant and equipment | 25,385 | 85,192 | |||
Proceeds from sale of non current assets classified as held for sale (net) | 50,820 | ||||
Interest received on balances with banks | 2,956 | 238 | |||
Net cash used in investing activities | (514,178) | (437,998) | |||
Cash flow from financing activities | |||||
Repayment of long term financing | (729,904) | (384,524) | |||
Repayment of lease liabilities | (4,216) | (4,041) | |||
Dividends paid | (200) | (450) | |||
Net cash used in financing activities | (734,320) | (389,015) | |||
Net Increase in cash and cash equivalents | 1,214,140 | 355,042 | |||
Cash and cash equivalents at beginning of the period | (1,424,347) | (2,524,119) | |||
Cash and cash equivalents at end of the period | 14 | (210,207) | (2,169,077) | ||
The annexed notes 1 to 20 form an integral part of these condensed interim financial statements.
ge L/
ecrefa
Page 4 of 4
